Poly(amino acid) Copolymers as a Potential Soluble Drug Delivery System. 1. Pinocytic Uptake and Lysosomal Degradation Measured In Vitro

Abstract

The suitability of poly(amino acid) copolymers as soluble drug- carriers is determined in part by their rate of pinocytic uptake by cells and intracellular degradation. Poly(amino acid) copolymers, poly(GluNa,Tyr) (1:1) or (4:1) and poly(GluNa,Tyr,Ala) (1:1:1) or (6:3:1) were radioiodinated and their rate of uptake and intracellular degradation measured using rat visceral yolk sacs cultured in vitro as a model system. Pinocytic uptake of these poly(amino acid) copolymers was 10-100 times greater than the rate measured for fluid- phase pinocytosis in the yolk sac, and it was dependent on their composition, poly(GluNa,Tyr) (4:1) being captured fastest. Inhibition of tissue association of radioactivity by incubation at 4°C confirmed uptake to be an active process. Intracellular degradation proceeded rapidly in all cases and was similarly related to copolymer amino acid composition. When the ¹²⁵I-labelled poly- (amino acid) copolymers were incubated with isolated rat liver lysosomal en zymes they were degraded to yield TCA soluble radioactivity, poly(GluNa, Tyr,Ala) (6:3:1) being degraded most rapidly (completely degraded within 2h) and poly(GluNa,Tyr) (1:1) degraded very slowly. Lysosomal thiol-dependent (cysteine) proteinases were partly responsible for the observed degradation as judged by leupeptin (24μg/ml) inhibition of degradation.

Keywords

ABBREVIATIONS: Tyr: L-Tyrosine GluNa: L-Glutamic Acid Sodium Salt Ala: L-Alanine

Get full access to this article

View all access options for this article.

References

Sidman, K.R. , A.D. Schwope , W.D. Steber and S.E. Rudolph in Naltrexone Monograph 28. R. E. Willette and G. Barnett , eds. National Institute on Drug Abuse, p. 214 (1980).

Shen, W.C. and H.J-P. Ryser . Proc. Natl. Acad Sci. U.S.A., 75:1872 (1978).

Duskin, D. , E. Katchalski-Katzir and L. Sachs. Febs. Letts., 60:21 (1975).

Van Heeswijk, W.A.R. , C.J.T. Hoes , T. Stoffer , M.J.D. Eenink , W. Patman and J. Feijen. J. Controlled Release, 1:301 ( 1985).

Campbell, P. , G.I. Glover and J.M. Gunn. Arch. Biochem. Biophys., 203:676 (1980).

Rihova, B. CRC Critical Reviews in Therapeutic Drug Carrier Systems, 1:311 ( 1985).

Williams, K.E. , E.M. Kidston , F. Beck and J.B. Lloyd. J. Cell. Biol. , 64:113 (1975).

Williams, K.E. , E.M. Kidston , F. Beck and J.B. Lloyd. J. Cell. Biol. , 64:123 (1975).

Duncan, R. , P. Rejmanová , J. Kopeček and J.B. Lloyd. Biochim. Biophys. Acta., 678:143 (1981).

10.

McCormick, L.A. and R. Duncan. J Bioactive Comp. Polymers , 4(3): 242-251 (1989).

11.

Lowry, O.H. , N.J. Rosebrough , A.L. Farr and R.J. Randall. J Biol. Chem. , 193:265 (1951).

12.

Duncan, R. and J.B. Lloyd. Biochim. Biophys. Acta., 544:647 (1978).

13.

Trouet, A. in Methods in Enzymology Vol. 21. E. Fleischer and L. Pocker , eds. N.Y.:Academic Press, p. 323 (1974).

14.

Duncan, R. , H. Cable , J.B. Lloyd , P. Rejmanová and J. Kopeček . Makromol. Chem., 184:1997 (1983 ).

15.

Duncan, R. and J. Kopeček . Adv. Polymer Sci., 57:51 (1984).

16.

Duncan, R. in Controlled Drug Delivery. J. R. Robinson and V. H. L. Lee , eds. N.Y.:Marcel Dekker, Inc., p. 582 (1987).

17.

Duncan, R. , H.C. Cable , F. Rypacek , J. Drobnik and J.B. Lloyd. Biochim. Biophys. Acta., 799:1 (1984).

18.

Duncan, R. , H.C. Cable , P. Rejmanová , J. Kopeček and J.B. Lloyd. Biochim. Biophys. Acta., 799:1 (1984).

19.

McCormick, L.A. , L.W. Seymour , R. Duncan and J. Kopeček. J Bioactive Comp. Polymers, 1:4 ( 1986).

20.

Duncan, R. , H.C. Cable , J. Strohalm and J. Kopeček . Bioscience Reps., 6:869 (1987).

21.

Livesey, G. and K.E. Williams. Biochem. J, 198:581 (1981).

22.

Barrett, A.J. and H. Kirschke. Methods in Enzymology, 80:535 (1981).

23.

Rejmanová, P. , J. Pohl , J. Baudys , V. Kostka and J. Kopeček. Makromol. Chem., 184:2009 (1983).